Toward Better Models of Hyperthyroid Graves' Disease

Endocrinology and Metabolism Clinics of North America

Volumn 38, Issue 2, 2009, Pages 343-354

  Daǧdelen, Selçuk ^a,b   Kong, Yi chi M ^c   Banga, J Paul ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HACETTEPE UNIVERSITY   (Turkey)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Experimental models; Graves' disease

Indexed keywords

MONOCLONAL ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN;

ADENOVIRUS; GENE TARGETING; GRAVES DISEASE; HYPERTHYROIDISM; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; GRAVES DISEASE; HUMANS;

ANIMALIA;

EID: 62749159966     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.01.003     Document Type: Review

References (65)

1. Nagayama Y., Kaufman K.D., Seto P., et al. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165 3 (1989) 1184-1190
2. Libert F., Lefort A., Gerard C., et al. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun 165 3 (1989) 1250-1255
3. Misrahi M., Loosfelt H., Atger M., et al. Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun 166 1 (1990) 394-403
4. Frazier A.L., Robbins L.S., Stork P.J., et al. Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing. Mol Endocrinol 4 8 (1990) 1264-1276
5. Shimojo N., Kohno Y., Yamaguchi K., et al. Induction of Graves'-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci U S A 93 20 (1996) 11074-11079
6. Bottazzo G.F., Pujol-Borrell R., Hanafusa T., et al. Role of aberrant HLA-DR expression and antigen presentation in induction of thyroid autoimmunity. Lancet 2 8359 (1983) 1115-1119
7. Banga J.P. The long and winding road for an experimental model of hyperthyroid Graves' disease. In: Wiersinga W.M., Drexhage H.A., and Weetman A.P. (Eds). The thyroid and autoimmunity (2007), Verlag, Stuttgart 118-125
8. Kita M., Ahmad L., Marians R.C., et al. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease. Endocrinology 140 3 (1999) 1392-1398
9. Ando T., Imaizumi M., Graves P., et al. Induction of thyroid stimulating hormone receptor autoimmunity in hamsters. Endocrinology 144 2 (2003) 671-680
10. Kaithamana S., Fan J., Osuga Y., et al. Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol 163 9 (1999) 5157-5164
11. Land K.J., Moll J.S., Kaplan M.H., et al. Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat-4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism. Endocrinology 145 8 (2004) 3724-3730
12. Costagliola S., Rodien P., Many M.C., et al. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol 160 3 (1998) 1458-1465
13. Costagliola S., Many M.C., Denef J.F., et al. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest 105 6 (2000) 803-811
14. Barrett K., Liakata E., Rao P.V., et al. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor. Clin Exp Immunol 136 3 (2004) 413-422
15. Pichurin P., Yan X.M., Farilla L., et al. Naked TSH receptor DNA vaccination: a Th1 T cell response in which interferon g production rather than antibody dominates the immune response in mice. Endocrinology 142 8 (2001) 3530-3536
16. Rao P.V., Watson P.F., Weetman A.P., et al. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination. Endocrinology 144 1 (2003) 260-266
17. Baker G., Mazziotti G., von Ruhland C., et al. Reevaluating thyrotropin receptor induced mouse models of Graves' disease and ophthalmopathy. Endocrinology 146 2 (2005) 835-844
18. Kong Y.M. Recent developments in the relevance of animal models to Hashimoto's thyroiditis and Graves' disease. Curr Opin Endocrinol Diabetes Obes 4 (1997) 347-353
19. Flynn J.C., Rao P.V., Gora M., et al. Graves' hyperthyroidism induced in HLA-DRB1*0301 (DR3) transgenic mice by immunization with thyrotropin receptor DNA. Clin Exp Immunol 135 1 (2004) 35-40
20. Pichurin P., Chen C.R., Pichurina O., et al. Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b. Thyroid 13 10 (2003) 911-917
21. Bangari D.S., and Mittal S.K. Current strategies and future directions for eluding adenoviral vector immunity. Curr Gene Ther 6 2 (2006) 215-226
22. Nagayama Y., Kita-Furuyama M., Ando T., et al. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168 6 (2002) 2789-2794
23. Jaume J.C., Rapoport B., and McLachlan S.M. Lack of female bias in a mouse model of autoimmune hyperthyroidism (Graves' disease). Autoimmunity 29 4 (1999) 269-272
24. Cooper D.S. Hyperthyroidism. Lancet 362 9382 (2003) 459-468
25. Nagayama Y., and Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol 6 2 (1992) 145-156
26. McLachlan S.M., Nagayama Y., and Rapoport B. Insight into Graves' hyperthyroidism from animal models. Endocr Rev 26 6 (2005) 800-832
27. Chazenbalk G.D., Pichurin P., Chen C.R., et al. Thyroid stimulating autoantibodies in Graves' disease preferentially recognize the free A subunit, not the thyrotropin receptor holoreceptor. J Clin Invest 110 2 (2002) 209-217
28. Chen C.R., Pichurin P., Nagayama Y., et al. The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. J Clin Invest 111 12 (2003) 1897-1904
29. Gilbert J.A., Gianoukakis A.G., Salehi S., et al. Monoclonal pathogenic antibodies to the TSH receptor in Graves' disease with potent thyroid stimulating activity, but differential blocking activity activate multiple signaling pathways. J Immunol 176 8 (2006) 5084-5092
30. Land K.J., Gudapati P., Kaplan M.H., et al. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289 adenovirus induced model of Graves' hyperthyroidism. Endocrinology 147 1 (2006) 111-119
31. Chen C.R., Pichurin P., Chazenbalk G.D., et al. Low dose immunization with adenovirus expressing the thyroid stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease. Endocrinology 145 1 (2004) 228-233
32. Mizutori Y., Saitoh O., Eguchi K., et al. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice. J Autoimmun 26 1 (2006) 32-36
33. Ando T., Latif R., and Davies T.F. Concentration dependent regulation of thyrotropin receptor function by thyroid stimulating antibody. J Clin Invest 113 11 (2004) 1589-1595
34. Costagliola S., Bonomi M., Morgenthaler N., et al. Delineation of the discontinuous conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18 12 (2004) 3020-3034
35. Flynn J.C., Gilbert J.A., Meroueh C., et al. Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice. Immunology 122 2 (2007) 261-267
36. Rees Smith B., McLachlan S.M., and Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 9 1 (1988) 106-121
37. Kaneda T., Honda A., Hakozaki A., et al. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice. Endocrinology 148 5 (2007) 2335-2344
38. Rapoport B., Alsabeh R., Aftergood D., et al. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 10 8 (2000) 685-692
39. Many M.C., Costagliola S., Detrait M., et al. Development of an animal model of autoimmune thyroid disease. J Immunol 162 8 (1999) 4966-4974
40. Yamada M., Li A.W., West K.A., et al. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor. Autoimmunity 35 6 (2002) 403-413
41. Smith T.J., and Hoa N. Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metab 89 10 (2004) 5076-5080
42. Ng H.P., Banga J.P., and Kung A.W. Development of a murine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase. Endocrinology 145 2 (2004) 809-816
43. + regulatory T cells in a mouse model. Endocrinology 147 5 (2006) 2417-2422
44. + T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model. Endocrinology 148 12 (2007) 6040-6046
45. + regulatory T cell-depleted mice. Cancer Res 65 18 (2005) 8471-8478
46. McLachlan S.M., Nagayama Y., Pichurin P.N., et al. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology 148 12 (2007) 5724-5733
47. Pichurin P., Schwarz-Lauer L., Braley-Mullen H., et al. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Thyroid 12 9 (2002) 755-764
48. Martin A., Nakashima M., Zhou A., et al. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease. J Clin Endocrinol Metab 82 10 (1997) 3361-3366
49. Soliman M., Kaplan E., Yanagawa T., et al. T cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain. J Clin Endocrinol Metab 80 3 (1995) 905-914
50. Banga J.P., Nielsen C.H., Gilbert J.A., et al. Application of new therapies in Graves' disease and thyroid associated ophthalmopathy: animal models and translation to human clinical trials. Thyroid 18 9 (2008) 973-981
51. Mosmann T.R., and Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
52. Steinman L. A brief history of TH17, the first major revision in the Th1/Th2 hypothesis of T cell mediated tissue damage. Nat Med 13 2 (2007) 139-145
53. Morris GP, Brown NK, Kong YC. Naturally existing CD4+CD25+Foxp3+ regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun, in press.
54. Dogan R.N., Vasu C., Holterman M.J., et al. Absence of IL4, and not suppression of Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 170 4 (2003) 2195-2204
55. Nagayama Y., Mizuguchi H., Hayakawa T., et al. Prevention of autoantibody-mediated Graves' like hyperthyroidism in mice with IL4, a Th2 cytokine. J Immunol 170 7 (2003) 3522-3527
56. Nagayama Y., Watanabe K., Niwa M., et al. Schistosoma mansoni and a-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol 173 3 (2003) 2167-2173
57. Nagayama Y., Saitoh O., McLachlan S.M., et al. TSH receptor adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice: implications for the Th1/Th2 paradigm. Clin Exp Immunol 138 3 (2004) 417-422
58. Dillon S.R., Gross J.A., Ansell S.M., et al. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5 3 (2006) 235-246
59. Mackay F., Silveira P.A., and Brink R. B cells and the BAFF/APRIL axis: fast forward on autoimmunity and signaling. Curr Opin Immunol 19 3 (2007) 327-336
60. Ingold K., Zumsteg A., Tardivel A., et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201 9 (2005) 1375-1383
61. Gilbert J.A., Kalled S.L., Moorhead J., et al. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumour necrosis factor family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 147 10 (2006) 4561-4568
62. Wang S.H., and Baker J.R. Targeting B cells in Graves' disease. Endocrinology 147 10 (2006) 4559-4560
63. Stohl W. BlySfulness does not equal BlissFulness in systemic lupus erythematosus: a therapeutic role for BlyS antagonists. Curr Dir Autoimmun 8 (2005) 289-304
64. Martinez O., Gangi E., Mordi D., et al. Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses. Endocrinology 148 2 (2007) 752-761
65. Sanders J., Jeffreys J., Depraetere H., et al. Thyroid-stimulating monoclonal antibodies. Thyroid 12 12 (2002) 1043-1050